Disclosures for "Real-World Effectiveness of Eptinezumab after Treatment with Subcutaneous CGRP Monoclonal Antibodies in Patients with Migraine")
-
Miss Casaletto has nothing to disclose.
-
Dr. Yang has nothing to disclose.
-
Mr. Waters has nothing to disclose.
-
Mr. Curran has nothing to disclose.
-
Mr. Lowe has nothing to disclose.
-
An immediate family member of Dr. Yuan has received personal compensation for serving as an employee of Merck. Dr. Yuan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Trillen Medical. The institution of Dr. Yuan has received research support from NIH. Dr. Yuan has received publishing royalties from a publication relating to health care. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as a Grant reviewer with NIH.